Norwood, MA (PRWEB) September 14, 2012
BioPharm Insight has been selected by PR Newswire Asia as its sole media source for their roundtable event discussing the challenges new media platforms have posed to the healthcare industry in China. The event will also feature ten leading pharmaceutical companies describing the challenges presented by new and expanding media channels.
Ying Huang, Bureau Editor of China Healthcare for BioPharm Insight, will discuss developing trends within the pharmaceutical industry to help better cater to these new PR challenges.
“We are honored that PR Newswire Asia has selected BioPharm Insight as the exclusive media representative for this important discussion,” said Huang. “We are looking forward to the opportunity to learn from our colleagues in the pharmaceutical industry while sharing what we have gathered about new and upcoming developments in China.”
With the development of new media outlets, the mass media industry has now become increasingly diversified inducing discussions on whether healthcare PR is ready for a complicated future.
Changes in the traditional media system and structure and the necessity for better search engine management to effectively communicate via various media outlets will be topics of discussion.
Participation in this discussion further solidifies BioPharm Insight’s position as the go-to resource for market intelligence and analytics across the globe.
About BioPharm Insight
Based in Hong Kong and Shanghai, BioPharm Insight supports the Asia-Pacific healthcare sector with proprietary intelligence, market analytics and key industry contacts. To learn more, sign up for free trial access.
About Infinata, Inc.
Featuring a comprehensive BioPharm Solutions Suite, unique Wealth Prospecting tools and innovative Custom Data Services, Infinata provides personalized technology solutions to turn information into insight. Infinata is a part of Mergermarket, a Financial Times Group company and a division of Pearson plc. To learn more, visit http://www.infinata.com.